提高KIF2C表达率通过调节Wnt/β-Catenin信号通路并促进免疫抑制瘤微环境,推动骨髓瘤的进展
Ya-Yun Liu1, Wu Sun2, Lin Liu3
1Department of Orthopaedics, Jiangxi Provincial People's Hospital, the First Affiliated Hospital of Nanchang Medical College, Nanchang, People's Republic of China.
Cancer medicine
|April 28, 2025
概括
素家族成员2C (KIF2C) 通过激活Wnt/β-catenin信号传递和创建免疫抑制瘤微环境来驱动骨髓瘤 (OS) 的进展. 准KIF2C为OS提供了一个潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 素家族成员2C (KIF2C) 与各种癌症有关,但其在骨髓瘤 (OS) 中的具体作用及其对瘤微环境的影响尚不清楚.
- 研究KIF2C在OS中的功能对于开发向疗法至关重要.
研究的目的:
- 阐明KIF2C在骨髓瘤 (OS) 发展和进展中的作用.
- 探索潜在的分子机制,包括路径激活和免疫微环境调制.
- 为了确定潜在的治疗点和OS的抑制剂.
主要方法:
- 分析公开数据集的KIF2C表达,诊断和预后意义在OS.
- 在体外和体内测试以评估KIF2C对OS细胞和瘤生长的功能影响.
- 基因组缩,基因组变异分析 (GSVA) 和单细胞测序以调查途径和免疫背景.
- 分子对接和动力学模拟以确定潜在的KIF2C抑制剂.
主要成果:
- 在OS中KIF2C过度表达,使其与正常组织区别开来,并与预后不佳相关.
- 在KIF2C Knockdown中,它可以抑制OS细胞的增殖,迁移,入侵和瘤生长,同时促进亡.
- KIF2C与β-catenin相互作用,调节Wnt/β-catenin通路,并有助于免疫抑制瘤微环境.
- 布丁蛋白被确定为潜在的小分子抑制剂,向KIF2C.
结论:
- KIF2C通过Wnt/β-catenin信号传递和免疫抑制微环境促进OS的进展.
- 准KIF2C为骨髓瘤治疗提供了一个有前途的治疗途径.
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
02:17The Tumor Microenvironment
6.4K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.4K
02:54Canonical Wnt Signaling Pathway
8.6K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.6K
01:22PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
01:41Non-Canonical Wnt Signaling Pathways
7.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.2K
02:38Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K